Cyclin D1 expression in renal carcinomas and oncocytomas: An immunohistochemical study

Modern Pathology

Volumn 11, Issue 11, 1998, Pages 1075-1081

  Lin, Bryan T Y ^a   Brynes, Russell K ^b   Gelb, Arnold B ^c   McCourty, Althea ^b   Amin, Mahul B ^d   Medeiros, L Jeffrey ^e  

^a Departments of Pathology   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c KAISER PERMANENTE MEDICAL CENTER   (United States)

^d HENRY FORD HOSPITAL   (United States)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Carcinoma; Cyclin D1; Fluorescence in situ hybridization; Immunohistochemistry; Kidney; Oncocytoma

Indexed keywords

CYCLIN D1; MONOCLONAL ANTIBODY;

ARTICLE; CHROMOSOME 11; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; ONCOCYTOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOCARCINOMA; ADENOCARCINOMA, CLEAR CELL; ADENOMA, OXYPHILIC; CARCINOMA, PAPILLARY; CARCINOMA, RENAL CELL; CELL NUCLEUS; CYCLIN D1; DISEASE-FREE SURVIVAL; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; KIDNEY NEOPLASMS; SURVIVAL ANALYSIS;

EID: 0031787209     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Sherr CJ. Mammalian G1 cyclins. Cell 1993;73:1059-65.
2. Hunter T, Pines J. Cyclins and cancer: Part II. Cyclin D and CDK inhibitors come of age. Cell 1994;79:573-82.
3. Xiong Y, Menninger J, Beach D, Ward DC. Molecular cloning and chromosomal mapping of CCND genes encoding human D-type cyclins. Genomics 1992;13:574-84.
4. Weisenburger DD, Armitage JO. Mantle cell lymphoma: an entity comes of age. Blood 1996;87:4483-94.
5. Rimokh R, Berger F, Delsol G, Chanin C, Bertheas MF, Ffrench M, et al. Rearrangement and overexpression of the bcl-1/PRAD-1 gene in intermediate lymphocytic lymphomas and in t(11q13)-bearing leukemias. Blood 1993;81:3063-7.
6. Arnold A, Kim HG, Gaz RD, Eddy RL, Fukushima Y, Byers MG, et al. Molecular cloning and chromosomal mapping of DNA rearranged with the parathyroid hormone gene in a parathyroid adenoma. J Clin Invest 1989;83:2034-40.
7. Barnes DM. Cyclin D1 in mammary carcinoma. J Pathol 1997;181:267-9.
8. Michalides R, van Veelen N, Hart A, Loftus B, Wientjens E, Balm A. Overexpression of cyclin D1 correlates with recurrence in a group of 47 operable squamous cell carcinomas of the head and neck. Cancer Res 1995;55:975-8.
9. Sheyn I, Noffsinger AE, Heffelfinger S, Davis B, Miller MA, Fenoglio-Preiser CM. Amplification and expression of the cyclin D1 gene in anal and esophageal squamous cell carcinomas. Hum Pathol 1997;28:270-6.
10. Jares P, Fernandez PL, Campo E, Nadal A, Bosch F, Aiza G, et al. PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Cancer Res 1994;54:4813-7.
11. Bringuier PP, Tamini Y, Schuuring E, Schalken J. Expression of cyclin D1 and EMS1 in bladder tumours: relationship with chromosome 11q13 amplification. Oncogene 1996;12:1747-53.
12. Lee CCR, Yamamoto S, Morimura K, Wanibuchi H, Nishisaka N, Ikemoto S, et al. Significance of cyclin D1 overexpression in transitional cell carcinomas of the urinary bladder and its correlation with histopathologic features. Cancer 1996;79:780-9.
13. Vasef MA, Medeiros LJ, Koo C, McCourty A, Brynes RK. Cyclin D1 immunohistochemical staining is useful in distinguishing mantle cell lymphoma from other low-grade B-cell neoplasms in the bone marrow. Am J Clin Pathol 1997;108: 302-7.
14. Bartkova J, Lukas J, Muller H, Strauss M, Gusterson B, Bartek J. Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer. Cancer Res 1995;55:949-56.
15. Bartkova J, Lukas J, Strauss M, Bartek J. Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis. Oncogene 1995;10:775-8.
16. Hung W-C, Chai C-Y, Huang J-S, Chuang L-Y. Expression of cyclin D1 and c-Ki-ras gene product in human epithelial ovarian tumors. Hum Pathol 1996;27:1324-28.
17. Wilczynski SP, Lin BTY, Xie Y, Paz IP. Detection of human papillomavirus DNA and oncoprotein overexpression are associated with distinct morphological patterns of tonsillar squamous cell carcinoma. Am J Pathol 1998;152:145-56.
18. Gelb AB, Sudilovsky D, Wu CD, Weiss LM, Medeiros LJ. Appraisal of intratumoral microvessel density, proliferation rate, DNA ploidy, and p53 protein expression as prognostic indicators in locally confined renal cell carcinoma. Cancer 1997;80:1768-75.
19. Kovacs G, Akhtar M, Beckwith BJ, Bugert P, Cooper CS, Delahunt B, et al. The Heidelberg classification of renal cell tumours. J Pathol 1997;183:131-3.
20. Storkel S, Eble JN, Adlakha K, Amin M, Blute ML, Bostwick DG, et al. Classification of renal cell carcinoma. Cancer 1997;80:987-9.
21. Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982;6:655-63.
22. Brynes RK, McCourty A, Tamayo R, Jenkins K, Battifora H. Demonstration of cyclin D1 (bcl-1) in mantle cell lymphoma: enhanced staining using heat and ultrasound epitope retrieval. Appl Immunohistochem 1997;5:45-8.
23. Kuroda H, Komatsu H, Nakamura S, Niitsu Y, Takahashi T, Ueda R, et al. The positive nuclear staining observed with monoclonal antibody against PRAD-1/cyclin D1 correlates with mRNA expression in mantle cell lymphoma. Jpn J Cancer Res 1995;86:890-8.
24. McIntosh GG, Anderson JJ, Milton I, Steward M, Parr AH, Thomas MD, et al. Determination of the prognostic value of cyclin D1 overexpression in breast cancer. Oncogene 1995; 11:885-91.
25. Brynes RK, McCourty A, Ho JP, Traweek ST, Snyder DS, Slovak ML. Detection of the Philadelphia chromosome in paraffin-embedded tissue by fluorescence in situ hybridization. Mod Pathol 1994;7:565-9.
26. Mu XC, Hou J, Nazeer T, Ross JS. Cell cycle regulators in primary renal cell carcinoma [abstract] Mod Pathol 1998;11: 90A.
27. Simpson JF, Quan DE, O'Malley F, Odom-Maryon T, Clarke PE. Amplification of CCND-1 and expression of its protein product, cyclin D1, in ductal carcinoma in situ of the breast. Am J Pathol 1997;151:161-8.
28. Kovacs G. Molecular cytogenetics of renal cell tumors. Adv Cancer Res 1993;62:89-124.
29. Crotty TB, Lawrence KM, Moertel CA, Bartelt DH, Batts KP, Dewald GW, et al. Cytogenetic analysis of six renal oncocytomas and a chromophobe cell renal carcinoma: evidence that -Y, -1 may be a characteristic anomaly in renal oncocytomas. Cancer Genet Cytogenet 1992;61:61-6.
30. Dobin SM, Harris CP, Reynolds JA, Coffield KS, Klugo RC, Peterson RF, et al. Cytogenetic abnormalities in renal oncocytic neoplasms. Genes Chromosomes Cancer 1992;4:25-31.
31. van den Berg E, Dijkhuizen T, Storkel S, Brutel de la Rivierè G, Dam A, Mensink HJA, et al. Chromosomal changes in renal oncocytomas: evidence that t(5;11)(q35;q13) may characterize a second subgroup of oncocytomas. Cancer Genet Cytogenet 1995;79:164-8.
32. Sinke RJ, Dijkhuizen T, Olde Weghuis D, Merkx G, van den Berg E, Schuuring E, et al. Fine mapping of the human renal oncocytoma-associated translocation (5;11)(q35;q13) breakpoint. Cancer Genet Cytogenet 1997;96:95-101.